Literature DB >> 2512894

Plaque quantitation and virus neutralization assays for human astroviruses.

R W Hudson1, J E Herrmann, N R Blacklow.   

Abstract

Astroviruses, 28 nm-diameter, RNA-containing viruses which have been implicated in gastroenteritis can be cultivated in cell cultures containing trypsin, but do not show distinguishable cytopathic effects. However, with the 5 known astrovirus serotypes which we have been able to cultivate, 3 (types 1, 2, and 5) formed well-defined plaques in LLCMK2 cell cultures under an agar overlay containing trypsin. A virus neutralization assay based on plaque reduction was applied to these 3 serotypes. It was found that rabbit antisera prepared against individual serotypes neutralized virus type-specifically, and no cross-neutralization titers were obtained with any of the antisera to the 5 astrovirus serotypes. The type-specific neutralization observed agreed with the specificities seen by immunofluorescence (IF), whereas ELISA tests with the same antisera show cross-reactivity among all 5 serotypes. There was no virus neutralization detected with astrovirus monoclonal antibodies which were reactive with 5 serotypes by ELISA and IF. The results we have obtained permit quantitative techniques to be applied to epidemiological and biological studies of the human astroviruses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512894     DOI: 10.1007/bf01313740

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Enhancement of vaccinia virus plaque formation by trypsin.

Authors:  G E Gifford; D G Klapper
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

2.  Trypsin enhancement of rotavirus infectivity: mechanism of enhancement.

Authors:  S M Clark; J R Roth; M L Clark; B B Barnett; R S Spendlove
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  Antigenic characterization of cell-cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies.

Authors:  J E Herrmann; R W Hudson; D M Perron-Henry; J B Kurtz; N R Blacklow
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

4.  Serial propagation of astrovirus in tissue culture with the aid of trypsin.

Authors:  T W Lee; J B Kurtz
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

5.  Letter: 28 nm particles in faeces in infantile gastroenteritis.

Authors:  C R Madeley; B P Cosgrove
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

6.  Astrovirus gastroenteritis age distribution of antibody.

Authors:  J Kurtz; T Lee
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

7.  Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin.

Authors:  K Tobita; A Sugiura; C Enomote; M Furuyama
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

8.  Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera.

Authors:  S Matsuno; S Inouye; R Kono
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

9.  ENZYMATIC ENHANCEMENT OF INFECTIVITY OF REOVIRUS.

Authors:  R S SPENDLOVE; F L SCHAFFER
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

10.  Sensitive plaque neutralization assay for parainfluenza virus types 1, 2, and 3 and respiratory syncytial virus.

Authors:  J D Hawthorne; P Albrecht
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

View more
  8 in total

1.  Temporal synthesis of proteins and RNAs during human astrovirus infection of cultured cells.

Authors:  S S Monroe; S E Stine; L Gorelkin; J E Herrmann; N R Blacklow; R I Glass
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Cloning and characterization of human astrovirus immunoreactive epitopes.

Authors:  S M Matsui; J P Kim; H B Greenberg; L M Young; L S Smith; T L Lewis; J E Herrmann; N R Blacklow; K Dupuis; G R Reyes
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  Immunological characterization of the Marin County strain of astrovirus.

Authors:  J E Herrmann; W D Cubitt; R W Hudson; D M Perron-Henry; L S Oshiro; N R Blacklow
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing.

Authors:  J S Noel; T W Lee; J B Kurtz; R I Glass; S S Monroe
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 5.  Physical and chemical methods for enhancing rapid detection of viruses and other agents.

Authors:  J H Hughes
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

6.  Age-stratified seroprevalence of neutralizing antibodies to astrovirus types 1 to 7 in humans in The Netherlands.

Authors:  M P Koopmans; M H Bijen; S S Monroe; J Vinjé
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 7.  Astrovirus Diagnostics.

Authors:  Philippe Pérot; Marc Lecuit; Marc Eloit
Journal:  Viruses       Date:  2017-01-12       Impact factor: 5.048

8.  Development of a potential diagnostic monoclonal antibody against capsid spike protein VP27 of the novel goose astrovirus.

Authors:  Miao Zhang; Xuan Lv; Bei Wang; Shengzu Yu; Qi Lu; Ying Kan; Xiqiang Wang; Beiping Jia; Zhuangli Bi; Qing Wang; Yingqi Zhu; Guijun Wang
Journal:  Poult Sci       Date:  2021-12-23       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.